BIOMAT Database Logo BIOMAT Database Logo

Observational studies of drug safety. 1996

A M Walker, and M J Stampfer
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A M Walker, and M J Stampfer
Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities.
January 2016, EGEMS (Washington, DC),
A M Walker, and M J Stampfer
Observational studies of drug safety--aprotinin and the absence of transparency.
November 2006, The New England journal of medicine,
A M Walker, and M J Stampfer
Randomized clinical trials and observational studies in the assessment of drug safety.
May 2018, Revue d'epidemiologie et de sante publique,
A M Walker, and M J Stampfer
Observational studies of drug effectiveness.
January 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
A M Walker, and M J Stampfer
[Observational cohort studies. Overview and some examples from the field of drug safety].
January 2013, Lakartidningen,
A M Walker, and M J Stampfer
Observational evidence for determining drug safety.
March 2008, BMJ (Clinical research ed.),
A M Walker, and M J Stampfer
Evaluation of autoimmune safety signal in observational vaccine safety studies.
September 2012, Human vaccines & immunotherapeutics,
A M Walker, and M J Stampfer
The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines.
January 2021, Expert opinion on drug safety,
A M Walker, and M J Stampfer
Postmarketing studies of drug safety.
February 2011, BMJ (Clinical research ed.),
A M Walker, and M J Stampfer
Targeted learning in observational studies with multi-valued treatments: An evaluation of antipsychotic drug treatment safety.
April 2024, Statistics in medicine,
Copied contents to your clipboard!